Skip to content

The Safety and Efficacy of Catheter Ablation for Patients with Cardiac Arrhythmia in a Non-Fluoroscopic Lab: A Prospective, Multi-center, Observational Study

The Safety and Efficacy of Catheter Ablation for Patients with Cardiac Arrhythmia in a Non-Fluoroscopic Lab: A Prospective, Multi-center, Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064478
Enrollment
Unknown
Registered
2022-10-09
Start date
2022-09-27
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrhythmia

Interventions

Experimental group:Non-fluoro catheter ablation

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years. 2. Patients with atrial fibrillation/atrial flutter/atrial tachycardia or idiopathic ventricular arrhythmia. 3. Ablation procedures planned to be performed in a radiation-free catheter lab using Carto system-related technology. 4. Participate in this study voluntarily and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. With severe disease and expected survival of less than one year. 2. History of myocardial infarction, coronary artery bypass transplantation and percutaneous coronary intervention within 3 months. 3. Inner diameter of left chamber is greater than 50mm. 4. Ultrasonography indicated left ventricular ejection fraction < 40%. 5. NYHA cardiac function grade III or IV. 6. Heart or vascular malformations are not conducive to catheter surgery or vascular puncture. 7. Vulnerable groups, including persons with mental illness, persons with cognitive impairment, pregnant women, illiterates, etc. 8. Patients are known to be unable to complete postoperative follow-up. 9. Participating in or planning to participate in other interventional clinical studies during the study period.

Design outcomes

Primary

MeasureTime frame
No recurrence of arrhythmias occurred without antiarrhythmic drugs 3 to 12 months after the first ablation;Procedure-related serious adverse events;

Countries

China

Contacts

Public ContactJiang Chenyang

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

cyjiang@zju.edu.cn+86 13857190051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026